Navigation Links
Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket
Date:3/13/2008

Operating Financial Guidance Remains Unchanged and is Updated to Reflect On- going Public Company and Other Costs and Tax Rate Effects of Separation

BATESVILLE, Ind., March 13 /PRNewswire-FirstCall/ -- Hillenbrand Industries, Inc. (NYSE: HB) filed materials with the Securities and Exchange Commission (SEC) associated with investor communications related to the upcoming separation of its two operating companies: Hill-Rom, the company's medical technology business, and Batesville Casket, the company's death care business. The separation is expected to be completed by the end of March pending final clearance of the Form 10 of Batesville Holdings, Inc., to be the parent company for Batesville Casket, originally filed November 5, 2007 and last amended on March 13, 2008, and other conditions listed below.

A Form 8-K filing, consisting of presentation materials for each company, is posted on the SEC website at http://www.sec.gov and also can be viewed on the Hillenbrand website at http://www.hillenbrand.com.

FINANCIAL GUIDANCE SUMMARY FOR FY 2008

In order to provide investors additional financial information with respect to Hill-Rom and Batesville on a post-separation basis, our existing operational guidance has been supplemented to reflect future expectations for the balance of fiscal 2008 for each business. Updated financial guidance for both businesses is provided in schedules accompanying this release and in the presentation materials referenced above.

For fiscal year 2008, Hill-Rom Holdings, which will be the new name of Hillenbrand Industries following the separation, continues to expect revenue of $1.427 - 1
'/>"/>

SOURCE Hillenbrand Industries, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Hillenbrand Industries Announces Fourth Quarter 2007 Dividend
2. Hillenbrand Industries Announces Second Quarter 2008 Dividend
3. Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation
4. Hillenbrand Industries, Inc. Announces Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
5. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
6. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
7. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
8. Verdict One Releases Directory of Board Certified Attorneys for Consumers
9. Academy releases emergency preparedness tools to enable millions more people to shelter in place
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. MITEM Releases Blue Iris eLaborate 8.6
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
... Carolina at Chapel Hill have managed to isolate a...s in Cystic Fibrosis. Blocking this// system allow... thus may herald in new treatments for the disease...isease caused by a defective gene that produces a ...
...though they do not develop zits, the do have oily ... to differentiate the cells// in the sebaceous gla...search examines how a sebaceous gland is formed. ...st 11 issue of Cell, Elaine Fuchs, a Howard Hughes...
...leptic son in July 2004 has for the first time spo...ess, Carmichael who is at the Brockville// Psychia...ories. "I wouldn't want any family to go through ...rry. I miss my son very much." Carmichael was a ph...
...st condom manufacturing unit in the country, is al...ncludes a vibrating ring plus a condom, a three-in...ceptive for women," said HLL chairman cum managing...porters here, Friday. Initially all these product...
Other Medicine News:Health News:Cellular System Causing Destruction Of Faulty Proteins In Cystic Fibrosis Identified 2Health News:'Blimp1' Gene Linked To Oily Skin 2
(Date:9/4/2008)... real-time PCR testing for the diagnostic ... Sept. 4 /- The U.S. Food & Drug,Admi...aqMan(R) HBV Test,the first assay for quantitatin...est uses Roche,s real-time PCR technology to quant...nt,s blood. Doctors may use viral load,testing res...
(Date:9/4/2008)...r 4 /- Axentis Pharma AG has,initiate...and tolerability,of a new therapeutic formulation ... cystic fibrosis patients. The new formulation all...ed directly to the site of,infection. The forthcom...ferent doses of the new drug. Initial results are ...
(Date:9/3/2008)...inhua--,Pharmaceutical comp...nced,that it has enrolled the first subject into i...g Bronchitol in cystic fibrosis sufferers., The P...ross North,America, Argentina and Germany, and is ...roval to market Bronchitol for cystic fibrosis in ...
(Date:9/3/2008)...Vascular Disease Awareness Month, CHARLOTTESVILLE...ticals,LLC, a clinical-stage drug-development comp... unmet medical needs, announced today that it has ...trial of its lead drug,candidate trans sodium croc...n the clinicaltrials.gov Website, is investigating...
Breaking Medicine Technology:FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Molecular glue with new effect 10629 1Molecular glue with new effect 10629 2Webcast Alert 3A HCA Announces 4Q Year End 07 Earnings Report 10628 1Dako Selects Axeda for Remote Monitoring Reporting and Software Management of Cancer Diagnostic System 10625 1Dako Selects Axeda for Remote Monitoring Reporting and Software Management of Cancer Diagnostic System 10625 2Healthcare Technologies Ltd Announces the Change of its Name to 22NexGen Biofuels Ltd 22 2902 1
... 14, 2007 /PRNewswire-FirstCall/ -- Shire plc ,th...t/Hyperactivity,Disorder (ADHD), announced that it...tment portfolio at the American Psychiatric,Associ... in San,Diego. , "The upcoming clinical research t... to understanding the science of ADHD treatment,",...
...NESS WIRE)--May 15, 2007 - Gemin X Biotechnologies...he journal Blood,demonstrated that its lead compou...tro in Mantle Cell Lymphoma (MCL) cell lines and,p...-070) is a small,molecule specifically designed to... family, a validated cancer target, thus restoring...
Other Medicine Technology:Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 2Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 3Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 4Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 5Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 6Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 7Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3
...ries Freezing Stages fit easily onto most microtom...arts and need only the AC supply and a trickle of ...ediately and can be maintained indefinitely. Stag...g temperatures can be set for different kinds of t...
ELISA kit for the quantitative determination of autoantibodies to glutamic acid decarboxylase (GAD65) in serum
ELISA kit for the quantitative determination of autoantibodies to IA-2 in serum
RIA kit for the quantitative determination of autoantibodies to insulin in serum
Medicine Products: